Literature DB >> 27056160

Peripheral Reactive Hyperemia Index and Coronary Microvascular Function in Women With no Obstructive CAD: The iPOWER Study.

Marie Mide Michelsen1, Naja Dam Mygind2, Adam Pena3, Ahmed Aziz4, Daria Frestad5, Nis Høst6, Eva Prescott6.   

Abstract

OBJECTIVES: This study investigated whether digital reactive hyperemia index (RHI) measured by digital pulse amplitude tonometry is a sensitive indicator of coronary microvascular dysfunction (CMD).
BACKGROUND: CMD is an early marker of cardiovascular disease. However, CMD is a complex diagnosis and consists of multiple abnormalities of the coronary circulation. Impaired RHI is a noninvasive measure of peripheral vascular dysfunction that can identify individuals with acetylcholine induced coronary vascular dysfunction. It is largely unknown whether there is also an association between RHI and the endothelial-independent aspect of CMD assessed as a coronary flow velocity reserve (CFVR).
METHODS: We included 339 women with chest pain suggestive of angina pectoris and a diagnostic invasive coronary angiogram without significant coronary artery stenosis (<50%). CFVR was measured by transthoracic pulsed wave Doppler echocardiography during dipyridamole infusion (0.84 mg/kg). RHI was assessed by digital pulse amplitude tonometry. Participants were categorized in 3 RHI and 3 CFVR groups. We examined the association between CFVR and RHI and the distribution of cardiovascular risk factors between the CFVR and RHI groups.
RESULTS: CFVR and RHI were successfully measured in 322 participants. Median CFVR was 2.3 (interquartile range: 2.0 to 2.8) and median RHI was 2.1 (interquartile range: 1.6 to 2.6). No correlation was found between CFVR and RHI (Spearman's rho = -0.067, p = 0.23), and mean RHI did not differ between CFVR categories (p = 0.39). Participants with low CFVR were significantly older and had a significantly greater burden of hypertension, whereas participants with an impaired RHI had a higher body mass index and were more likely to have diabetes and be current smokers.
CONCLUSIONS: RHI does not identify individuals with CMD assessed as impaired CFVR by dipyridamole stress echocardiography in women with no obstructive coronary artery disease. The two methods are likely to identify different aspects of vascular pathology, as indicated by the different association with cardiovascular risk factors.
Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  coronary flow reserve; coronary microvascular function; microvascular angina pectoris; no obstructive coronary artery disease; peripheral microvascular function; reactive hyperemia index

Mesh:

Year:  2016        PMID: 27056160     DOI: 10.1016/j.jcmg.2016.02.005

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  18 in total

Review 1.  Non-invasive Risk Stratification for Coronary Artery Disease: Is It Time for Subclassifications?

Authors:  Pupalan Iyngkaran; Samer Noaman; William Chan; Gnanadevan Mahadavan; Merlin C Thomas; Sharmalar Rajendran
Journal:  Curr Cardiol Rep       Date:  2019-07-25       Impact factor: 2.931

2.  Spinal cord injury and vascular function: evidence from diameter-matched vessels.

Authors:  Massimo Venturelli; Markus Amann; Joel D Trinity; Stephen J Ives; Russell S Richardson
Journal:  J Appl Physiol (1985)       Date:  2020-12-03

Review 3.  Advanced Imaging and Diagnostic Methods in the Assessment of Suspected Ischemic Heart Disease in Women.

Authors:  Joanna M Joly; Vera Bittner
Journal:  Curr Cardiol Rep       Date:  2016-09       Impact factor: 2.931

4.  Effects of salvianolate on microcirculatory disturbance in patients with stable coronary heart disease: study protocol for a randomized controlled trial.

Authors:  Zhanlu Li; Yi Luan; Min Wang; Ya Li; Xiaohua Shen; Guosheng Fu; Wenbin Zhang
Journal:  Trials       Date:  2021-03-08       Impact factor: 2.279

5.  Coronary microvascular function and myocardial fibrosis in women with angina pectoris and no obstructive coronary artery disease: the iPOWER study.

Authors:  Naja Dam Mygind; Marie Mide Michelsen; Adam Pena; Abbas Ali Qayyum; Daria Frestad; Thomas Emil Christensen; Adam Ali Ghotbi; Nynne Dose; Rebekka Faber; Niels Vejlstrup; Philip Hasbak; Andreas Kjaer; Eva Prescott; Jens Kastrup
Journal:  J Cardiovasc Magn Reson       Date:  2016-11-04       Impact factor: 5.364

6.  Endothelial Function Is Associated with White Matter Microstructure and Executive Function in Older Adults.

Authors:  Nathan F Johnson; Brian T Gold; Christopher A Brown; Emily F Anggelis; Alison L Bailey; Jody L Clasey; David K Powell
Journal:  Front Aging Neurosci       Date:  2017-08-02       Impact factor: 5.750

7.  Evaluation of the systemic micro- and macrovasculature in stable angina: A case-control study.

Authors:  Ulf Neisius; Erin Olson; Sabrina H Rossi; Hagar A Ibrahim; Gemma Currie; Anna F Dominiczak; Christian Delles
Journal:  PLoS One       Date:  2017-05-25       Impact factor: 3.240

8.  Mental stress peripheral vascular reactivity is elevated in women with coronary vascular dysfunction: Results from the NHLBI-sponsored Cardiac Autonomic Nervous System (CANS) study.

Authors:  Puja K Mehta; Melody Hermel; Michael D Nelson; Galen Cook-Wiens; Elizabeth A Martin; Ayman A Alkhoder; Janet Wei; Margo Minissian; Chrisandra L Shufelt; Sailaja Marpuri; David Hermel; Amit Shah; Michael R Irwin; David S Krantz; Amir Lerman; C Noel Bairey Merz
Journal:  Int J Cardiol       Date:  2017-10-22       Impact factor: 4.039

9.  Comparison of the Peripheral Reactive Hyperemia Index with Myocardial Perfusion Reserve by 82Rb PET/CT in HIV-Infected Patients.

Authors:  Mathilde Ørbæk; Philip Hasbak; Rasmus Sejersten Ripa; Andreas Kjær; Anne-Mette Lebech; Andreas Knudsen
Journal:  Diagnostics (Basel)       Date:  2017-05-31

10.  Reactive Hyperemia Index Associated With Atherosclerotic Cardiovascular Disease Under Treatment for Lifestyle Diseases.

Authors:  Kota Motozato; Yasunori Suematsu; Kenji Norimatsu; Takaaki Kusumoto; Shin-Ichiro Miura
Journal:  J Clin Med Res       Date:  2020-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.